SCHEMBL2178410

SCHEMBL2178410

CC(C)(C)OC(=O)N(c1ccc(C#N)cc1)c1ccc(Br)c(CBr)c1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
MT-CO2 P00403 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
GSK3B P49841 1/20 0.33
CYP19A1 P11511 2/20 0.33
ABCB1 P08183 6/20 0.32
GPR119 Q8TDV5 2/20 0.32
SCN9A Q15858 1/20 0.32
NCEH1 Q6PIU2 1/20 0.32
AAK1 Q2M2I8 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180329 0.87 CHRNB2 (0.34) CHRNB2CHRNB4CHRNA3CHRNA4MT-CO2
SCHEMBL2179019 0.85 MT-CO2 (0.35) CHRNB2CHRNB4CHRNA3CHRNA4MT-CO2
SCHEMBL2176988 0.78 AAK1 (0.33) MT-CO2CTSSCTSKAAK1
SCHEMBL1164018 0.76 L3MBTL1 (0.37) MT-CO2CTSSCTSKGSK3B
SCHEMBL3868314 0.73 CHRNB2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4MT-CO2
SCHEMBL6650593 0.72 CHRNB2 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4ABCB1
SCHEMBL2178893 0.70 ABCB1 (0.34) CHRNB2CHRNB4CHRNA3CHRNA4ABCB1
SCHEMBL28847028 0.70 ABCB1 (0.38) CTSSCTSKCYP19A1ABCB1NCEH1
SCHEMBL38651897 0.70 MLYCD (0.50) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL12484843 0.70 PDE4B (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130289000-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS INC (US) 2013-10-31 US disclosed
US-8470803-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2013-06-25 US disclosed
US-20110166103-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166103-A1 BORON-CONTAINING SMALL MOLECULES NFKBIA, BCL6B, TNF CHRNB2 3527/4885CHRNB4 3916/4885CHRNA3 4634/4885
US-20130289000-A1 BORON-CONTAINING SMALL MOLECULES NFKBIA, BCL6B, TNF CHRNB2 3527/4885CHRNB4 3916/4885CHRNA3 4634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.